Labcorp Expands MRD Testing for Breast, Lung, and Colon Cancer Recurrence Risk
LabCorp
Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer
Lungs
New Report Highlights Opportunities to Improve Lung Cancer Outcomes Across the US
Today's Clinical Lab, American Lung Association
State of Lung Cancer 2025 identifies lessons from Delaware and other states to expand screening, increase biomarker testing coverage, and save lives
2025’s Cancer Dilemma: Finding Tests That Diagnose Cancer at the Right Time
Arnon Chait, PhD, MBA
As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes
Rates of Breast and Colorectal Cancer Screening Nearly Four-Fold Higher than Lung Cancer Screening, Study Finds
Mass General Brigham
A new study finds that many eligible patients who receive other preventive screenings are not getting screened for lung cancer
Tumor DNA in the Blood Can Predict Lung Cancer Outcome
The Francis Crick Institute
Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome
Women Are Less Likely to Get a Lung Transplant than Men and Spend 6 Weeks Longer on the Waiting List
European Respiratory Society
New study encourages changes in regulation and clinical guidelines to address inequality in lung transplantation
ASH 2024: Study Shows Genetic Mutations Accumulate in Smokers with Myelodysplastic Syndromes and Worsen Outcomes
University of Miami Miller School of Medicine
Study is the first to identify discrete genetic mutations associated with smoking, to establish a dose-response relationship between smoking and genetic mutations and to show that continuing to smoke leads to more mutations and worse MDS
Detecting Evidence of Lung Cancer in Exhaled Breath
American Chemical Society
Researchers have determined that declines in one particular exhaled chemical can indicate the presence of lung cancer
5 Clinical Laboratories Leading the Way in Patient Care
Michael Schubert, PhD
Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges
International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
Association for Molecular Pathology
The open comment period begins August 22 and will close on September 12, 2024